Your browser doesn't support javascript.
loading
EVI2B may be a novel prognostic marker for lung adenocarcinoma.
Fu, Yin; He, Junming; Chen, Jian; Hu, Jiangwei; Guan, Wei; Lou, Guoliang.
Afiliación
  • Fu Y; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
  • He J; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
  • Chen J; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
  • Hu J; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
  • Guan W; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
  • Lou G; Department of Cardiothoracic Surgery, Yiwu Central Hospital, Yiwu City, Zhejiang Province, 322000, China.
Biomark Med ; 17(14): 599-612, 2023 07.
Article en En | MEDLINE | ID: mdl-37843407
Lung adenocarcinoma (LUAD) is a type of cancer. It causes many deaths. However, there is no good treatment for it yet. Scientists found a gene called EVI2B. EVI2B can help show how bad the cancer is. EVI2B is at a low level in LUAD. When it is high, patients have a better chance of surviving. EVI2B is linked to the immune system fighting cancer. It can be used to check the progression of LUAD. EVI2B may help with new treatments in the future.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glicoproteínas de Membrana / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China